Form 4: Sotera Health Director Vincent K. Petrella Reports Acquisition of 20,089 Restricted Stock Units

Director Vincent K. Petrella reports acquisition of 20,089 Restricted Stock Units (RSUs) in Sotera Health Co.

Summary

• On May 24, 2024, Vincent K. Petrella, a director of Sotera Health Co., acquired 20,089 Restricted Stock Units (RSUs).
• These RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock, subject to vesting conditions.
• The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent upon continued service as a non-employee director.
• Following the transaction, Petrella beneficially owns 20,089 RSUs and 41,560 shares of Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a standard insider transaction, indicating continued alignment between the director and the company's performance. The sentiment is neutral to slightly positive due to the incentive structure.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and performance.

Future Outlook

The vesting of the RSUs is contingent upon continued service as a non-employee director, suggesting an expectation of continued involvement.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the holdings and activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• The Sotera Health Company 2020 Omnibus Incentive Plan is a common mechanism for aligning management and shareholder interests, similar to incentive plans used by companies like Steris and Medtronic.

Stakeholder Impact

• The RSU grant aligns the director's interests with shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates